Comparison of Cancer Care and Outcomes between a Public Safety-Net Hospital and a Private Cancer Center

被引:7
作者
Bayraktar, Ulas Darda [1 ]
Warsch, Sean [1 ]
Chen, Emerson [1 ]
Lima, Caio Max Rocha [1 ]
Pereira, Denise [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Med, Div Hematol Oncol, Coral Gables, FL 33124 USA
关键词
Colon cancer; lymphoma; treatment delay; disparities; safety-net hospital; LARGE-CELL LYMPHOMA; CHEMOTHERAPY PLUS RITUXIMAB; BREAST-CANCER; ADJUVANT CHEMOTHERAPY; HEALTH-INSURANCE; STAGE-II; SOCIOECONOMIC-STATUS; DOSE INTENSITY; COLON-CANCER; SURVIVAL;
D O I
10.1353/hpu.2013.0145
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We compared the cancer outcomes and care-associated service defects between Jackson Memorial Hospital (ABC), a large public safety-net hospital, and Sylvester Comprehensive Cancer Center (XYZ), a private not-for-profit cancer center in patients with stage II-III colorectal cancer (CC) who received adjuvant chemotherapy (AC) and in patients with diffuse large B cell lymphoma (DLBCL). Colorectal cancer patients treated at ABC were more likely to have undergone urgent surgery. While in the CC cohort, three-year overall survival and relapse-free survival rates were significantly higher among patients treated at XYZ compared with those treated at ABC, there was no significant difference between patients treated for DLBCL in the two hospitals. Colorectal cancer patients treated at ABC were more likely to have undergone urgent surgery, to have delays before surgery or during chemotherapy, and to experience a system/patient-related service defect; whereas were less likely to complete a full course of AC.
引用
收藏
页码:1136 / 1149
页数:14
相关论文
共 47 条
[1]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[2]   Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial [J].
Andre, Thierry ;
Boni, Corrado ;
Navarro, Matilde ;
Tabernero, Josep ;
Hickish, Tamas ;
Topham, Clare ;
Bonetti, Andrea ;
Clingan, Philip ;
Bridgewater, John ;
Rivera, Fernando ;
de Gramont, Aimery .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3109-3116
[3]  
[Anonymous], ASH ANN M
[4]  
[Anonymous], CANCER
[5]  
[Anonymous], CURERNT POPULATION R
[6]  
[Anonymous], HLTH COV UN
[7]   THE RELATION BETWEEN HEALTH-INSURANCE COVERAGE AND CLINICAL OUTCOMES AMONG WOMEN WITH BREAST-CANCER [J].
AYANIAN, JZ ;
KOHLER, BA ;
ABE, T ;
EPSTEIN, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (05) :326-331
[8]   American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer [J].
Benson, AB ;
Schrag, D ;
Somerfield, MR ;
Cohen, AM ;
Figueredo, AT ;
Flynn, PJ ;
Krzyzanowska, MK ;
Maroun, J ;
McAllister, P ;
Van Cutsem, E ;
Brouwers, M ;
Charette, M ;
Haller, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3408-3419
[9]  
BERG JW, 1977, CANCER-AM CANCER SOC, V39, P467, DOI 10.1002/1097-0142(197702)39:2<467::AID-CNCR2820390215>3.0.CO
[10]  
2-B